8 active trials 6 recruiting 1 Phase 3 4 disease areas 3 changes in 30 days
| Phase 1/2 | 1 | |
| Phase 2 | 4 | |
| Phase 3 | 1 | |
| Phase 4 | 1 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 4 | ||||
| NCT04781140 | Evaluation of SPN-812 (Viloxazine Extended-release Capsule) in Preschool-age Children… | Attention-Deficit/Hyperactivity Disorder | Recruiting | 2026-09-11 |
| Phase 3 | ||||
| NCT02736656 | Open-label Study to Evaluate Long-term Safety and Efficacy of SPN-812 (Viloxazine… | Attention-Deficit/Hyperactivity Disorder | Active, Not Recruiting | 2026-07-15 |
| Phase 2 | ||||
| NCT06798896 | RENAISSANCE 2: SPN-817 Phase 2, Double-Blind, Placebo-Controlled Study in Adults With… | Focal Onset Seizures | Recruiting | 2026-10-01 |
| NCT05518578 | Safety and Tolerability Study of SPN-817 in Adult Patients With Treatment Resistant… | Epilepsy | Recruiting | 2026-04-21 |
| NCT07226661 | Double-blind, Placebo-controlled Study in Adults With Major Depressive Disorder | Major Depressive Disorder (MDD) | Recruiting | 2026-03-24 |
| NCT07141329 | SPN-817 Open-Label Extension Study in Adults With Focal Onset Seizures | Focal Onset Seizures | Recruiting | 2025-10-10 |
| Phase 1/2 | ||||
| NCT03474770 | BIS-001-ER for the Treatment of Adult Focal Impaired Awareness Seizures | Focal Impaired Awareness Seizures | Active, Not Recruiting | 2022-08-30 |
| Not specified | ||||
| NCT07219927 | Real-World Patient Experiences Using Continuous Subcutaneous Apomorphine Infusion… | Parkinson Disease | Recruiting | 2025-10-22 |
Epilepsy (4) · ADHD (2) · Depression (1) · Parkinson's Disease (1)